TY - JOUR
T1 - Safety of off-label erythropoiesis-stimulating agents for critically ill patients
AU - Mesgarpour, Bita
AU - Heidinger, Benedikt H.
AU - Roth, Dominik
AU - Schmitz, Susanne
AU - Walsh, Cathal D.
AU - Herkner, Harald
N1 - Publisher Copyright:
© 2014 The Cochrane Collaboration.
PY - 2014/2/12
Y1 - 2014/2/12
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: With a focus on safety, we aim to assess the effects of ESAs (ESAs alone or in combination) compared with placebo, no treatment or a different active treatment regimen when administered off-label to critically ill patients. We will further describe and explore heterogeneity and will assess the influence of bias on the robustness of our effect estimates.
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: With a focus on safety, we aim to assess the effects of ESAs (ESAs alone or in combination) compared with placebo, no treatment or a different active treatment regimen when administered off-label to critically ill patients. We will further describe and explore heterogeneity and will assess the influence of bias on the robustness of our effect estimates.
UR - http://www.scopus.com/inward/record.url?scp=85028335263&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD010969
DO - 10.1002/14651858.CD010969
M3 - Article
AN - SCOPUS:85028335263
SN - 1465-1858
VL - 2014
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 2
M1 - CD010969
ER -